A clarification of the processing rules around the timing of a medicinal cannabis licence and narcotics manufacturing licences
Professor John McMillan AO appointed to review and report on the operation of the Narcotic Drugs Act 1967
The TGA will be hosting public meetings in February 2019 in Sydney, Brisbane and Melbourne
False and misleading claims made by some companies
Allowing the export of Australian-manufactured medicinal cannabis products
Doctors wishing to prescribe unregistered medicinal cannabis products under SAS Cat A
Response to public consultation is now available
Office of Drug control is seeking feedback on the potential export of medicinal cannabis
Imported medicinal cannabis products only, not domestically produced product, can now be supplied through SAS Cat A
The Office of Drug Control will be hosting two information and consultation sessions in July
